Quality of life in Prolactinoma: A systematic review

ConclusionPoor quality of life in prolactinoma is multifactorial, related to biochemical control, side effects of therapy, and sellar mass effect. Targeting persistent symptoms, reducing healthcare costs, and reducing side-effects of therapy are avenues to improving QOL in patients with prolactinoma.
Source: Pituitary - Category: Endocrinology Source Type: research